{"id":"https://openalex.org/W2965574501","doi":"https://doi.org/10.1111/ajco.13233","title":"Thymic hyperplasia following double immune checkpoint inhibitor therapy in two patients with stage IV melanoma","display_name":"Thymic hyperplasia following double immune checkpoint inhibitor therapy in two patients with stage IV melanoma","publication_year":2019,"publication_date":"2019-08-01","ids":{"openalex":"https://openalex.org/W2965574501","doi":"https://doi.org/10.1111/ajco.13233","mag":"2965574501","pmid":"https://pubmed.ncbi.nlm.nih.gov/31373116"},"language":"en","primary_location":{"id":"doi:10.1111/ajco.13233","doi":"https://doi.org/10.1111/ajco.13233","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ajco.13233","pdf_url":null,"source":{"id":"https://openalex.org/S77500791","display_name":"Asia-Pacific Journal of Clinical Oncology","issn_l":"1743-7555","issn":["1743-7555","1743-7563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia-Pacific Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089648243","display_name":"Justin Mencel","orcid":"https://orcid.org/0000-0002-1097-7953","observed_orcids":["https://orcid.org/0000-0002-1097-7953"]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I4210114644","display_name":"Northern Territory Health Services","ror":"https://ror.org/021ctjg87","country_code":"AU","type":"government","lineage":["https://openalex.org/I4210099692","https://openalex.org/I4210114644"]},{"id":"https://openalex.org/I4210137971","display_name":"Royal Darwin Hospital","ror":"https://ror.org/04jq72f57","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210137971"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Justin Mencel","raw_affiliation_strings":["Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia","Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia"],"raw_orcid":"https://orcid.org/0000-0002-1097-7953","affiliations":[{"raw_affiliation_string":"Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia","institution_ids":["https://openalex.org/I4210114644","https://openalex.org/I4210137971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081571370","display_name":"Tessa Gargett","orcid":"https://orcid.org/0000-0003-3713-1373","observed_orcids":["https://orcid.org/0000-0003-3713-1373"]},"institutions":[{"id":"https://openalex.org/I107656453","display_name":"South Australia Pathology","ror":"https://ror.org/01kvtm035","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I107656453"]},{"id":"https://openalex.org/I170239107","display_name":"University of South Australia","ror":"https://ror.org/01p93h210","country_code":"AU","type":"education","lineage":["https://openalex.org/I170239107","https://openalex.org/I4405259444"]},{"id":"https://openalex.org/I4210140852","display_name":"Centre for Cancer Biology","ror":"https://ror.org/03yg7hz06","country_code":"AU","type":"facility","lineage":["https://openalex.org/I107656453","https://openalex.org/I4210140852","https://openalex.org/I4405259444"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Tessa Gargett","raw_affiliation_strings":["Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I107656453","https://openalex.org/I170239107","https://openalex.org/I4210140852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076114432","display_name":"Narayan Vaderahobali Karanth","orcid":"https://orcid.org/0000-0002-3374-6242","observed_orcids":["https://orcid.org/0000-0002-3374-6242"]},"institutions":[{"id":"https://openalex.org/I4210114644","display_name":"Northern Territory Health Services","ror":"https://ror.org/021ctjg87","country_code":"AU","type":"government","lineage":["https://openalex.org/I4210099692","https://openalex.org/I4210114644"]},{"id":"https://openalex.org/I4210137971","display_name":"Royal Darwin Hospital","ror":"https://ror.org/04jq72f57","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210137971"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Narayan Karanth","raw_affiliation_strings":["Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia","institution_ids":["https://openalex.org/I4210114644","https://openalex.org/I4210137971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046994047","display_name":"Adrian M. J. Pokorny","orcid":"https://orcid.org/0000-0002-6987-0499","observed_orcids":["https://orcid.org/0000-0002-6987-0499"]},"institutions":[{"id":"https://openalex.org/I4210114644","display_name":"Northern Territory Health Services","ror":"https://ror.org/021ctjg87","country_code":"AU","type":"government","lineage":["https://openalex.org/I4210099692","https://openalex.org/I4210114644"]},{"id":"https://openalex.org/I4210137971","display_name":"Royal Darwin Hospital","ror":"https://ror.org/04jq72f57","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210137971"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Adrian Pokorny","raw_affiliation_strings":["Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia","institution_ids":["https://openalex.org/I4210114644","https://openalex.org/I4210137971"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021075431","display_name":"Michael Paul Brown","orcid":"https://orcid.org/0000-0002-5796-1932","observed_orcids":["https://orcid.org/0000-0002-5796-1932","https://orcid.org/0000-0002-0495-7315"]},"institutions":[{"id":"https://openalex.org/I107656453","display_name":"South Australia Pathology","ror":"https://ror.org/01kvtm035","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I107656453"]},{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I170239107","display_name":"University of South Australia","ror":"https://ror.org/01p93h210","country_code":"AU","type":"education","lineage":["https://openalex.org/I170239107","https://openalex.org/I4405259444"]},{"id":"https://openalex.org/I4210140852","display_name":"Centre for Cancer Biology","ror":"https://ror.org/03yg7hz06","country_code":"AU","type":"facility","lineage":["https://openalex.org/I107656453","https://openalex.org/I4210140852","https://openalex.org/I4405259444"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael P. Brown","raw_affiliation_strings":["Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia","Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia","School of Medicine, University of Adelaide, Adelaide, South Australia, Australia","Michael P. Brown and Michail Charakidis share co-senior authorship"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I107656453","https://openalex.org/I170239107","https://openalex.org/I4210140852"]},{"raw_affiliation_string":"School of Medicine, University of Adelaide, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Michael P. Brown and Michail Charakidis share co-senior authorship","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086954620","display_name":"Michail Charakidis","orcid":"https://orcid.org/0000-0003-0791-203X","observed_orcids":["https://orcid.org/0000-0003-0791-203X"]},"institutions":[{"id":"https://openalex.org/I4210114644","display_name":"Northern Territory Health Services","ror":"https://ror.org/021ctjg87","country_code":"AU","type":"government","lineage":["https://openalex.org/I4210099692","https://openalex.org/I4210114644"]},{"id":"https://openalex.org/I4210137971","display_name":"Royal Darwin Hospital","ror":"https://ror.org/04jq72f57","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210137971"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Michail Charakidis","raw_affiliation_strings":["Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia","Michael P. Brown and Michail Charakidis share co-senior authorship"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia","institution_ids":["https://openalex.org/I4210114644","https://openalex.org/I4210137971"]},{"raw_affiliation_string":"Michael P. Brown and Michail Charakidis share co-senior authorship","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5086954620"],"corresponding_institution_ids":["https://openalex.org/I4210114644","https://openalex.org/I4210137971"],"apc_list":{"value":3200,"currency":"USD","value_usd":3200},"apc_paid":null,"fwci":0.5595,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.65787951,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"15","issue":"6","first_page":"383","last_page":"386"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8988999724388123,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":0.0763000026345253,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thymic-hyperplasia","display_name":"thymic hyperplasia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.925000011920929},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9330000281333923},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/stage-iv-melanoma","display_name":"stage IV melanoma","score":0.8690000176429749},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9039999842643738},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/hydrocortisone-replacement-therapy","display_name":"hydrocortisone replacement","score":0.8299999833106995},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.796999990940094},{"id":"https://openalex.org/keywords/fdg-pet-ct-findings","display_name":"FDG PET/CT findings","score":0.7559999823570251},{"id":"https://openalex.org/keywords/thymus-histopathology","display_name":"thymus histopathology","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8295068740844727},{"id":"https://openalex.org/C2779159893","wikidata":"https://www.wikidata.org/wiki/Q1429863","display_name":"Thymoma","level":2,"score":0.7501504421234131},{"id":"https://openalex.org/C2777562237","wikidata":"https://www.wikidata.org/wiki/Q835051","display_name":"Hyperplasia","level":2,"score":0.6940659880638123},{"id":"https://openalex.org/C2778105408","wikidata":"https://www.wikidata.org/wiki/Q8285","display_name":"Myasthenia gravis","level":2,"score":0.5567147135734558},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.5066238045692444},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.45342278480529785},{"id":"https://openalex.org/C2777415128","wikidata":"https://www.wikidata.org/wiki/Q419849","display_name":"Fluorodeoxyglucose","level":3,"score":0.4355568289756775},{"id":"https://openalex.org/C2776349617","wikidata":"https://www.wikidata.org/wiki/Q7799620","display_name":"Thymic carcinoma","level":3,"score":0.4312697947025299},{"id":"https://openalex.org/C2779615886","wikidata":"https://www.wikidata.org/wiki/Q3090790","display_name":"Thymectomy","level":3,"score":0.419411301612854},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.41778337955474854},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41740715503692627},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.39664706587791443},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34655794501304626},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32463085651397705},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.30309122800827026},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.24806535243988037},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.15694409608840942},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.09841984510421753}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077594","descriptor_name":"Nivolumab","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000096142","descriptor_name":"Cutaneous Malignant Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012878","descriptor_name":"Skin Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013952","descriptor_name":"Thymus Hyperplasia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/ajco.13233","doi":"https://doi.org/10.1111/ajco.13233","is_oa":false,"landing_page_url":"https://doi.org/10.1111/ajco.13233","pdf_url":null,"source":{"id":"https://openalex.org/S77500791","display_name":"Asia-Pacific Journal of Clinical Oncology","issn_l":"1743-7555","issn":["1743-7555","1743-7563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","norway-1","poland-40","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia-Pacific Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:31373116","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31373116","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Asia-Pacific journal of clinical oncology","raw_type":"Case Reports"},{"id":"pmh:oai:digital.library.adelaide.edu.au:11541.2/138394","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11541.2/138394","pdf_url":null,"source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://doi.org/10.1111/ajco.13233","raw_type":"Journal article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320336970","display_name":"Royal Adelaide Hospital Research Fund","ror":"https://ror.org/000t0j841"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W1994642215","https://openalex.org/W2005031837","https://openalex.org/W2016757852","https://openalex.org/W2074909784","https://openalex.org/W2171583940","https://openalex.org/W2171995059","https://openalex.org/W2523517237","https://openalex.org/W2591019888","https://openalex.org/W2896600825","https://openalex.org/W2912304776"],"related_works":["https://openalex.org/W4405952839","https://openalex.org/W2809407916","https://openalex.org/W2788610539","https://openalex.org/W3021818069","https://openalex.org/W2769814019","https://openalex.org/W2560876009","https://openalex.org/W7161038192","https://openalex.org/W3205068818","https://openalex.org/W2973006665","https://openalex.org/W3159751597"],"abstract_inverted_index":{"Hyperplasia":[0],"of":[1,39,52,69,99,103,139,180,191],"the":[2,67,104,114,117,135,155,178,189],"thymus":[3,105],"is":[4,35],"commonly":[5],"seen":[6],"in":[7,57,159],"myasthenia":[8],"gravis":[9],"and":[10,23,71,82,96],"other":[11,115],"autoimmune":[12],"disorders.":[13],"Thymic":[14],"size":[15],"also":[16,85,128],"varies":[17],"with":[18,43,59,66,109,129],"age,":[19],"corticosteroid":[20,80,170],"use,":[21],"infections,":[22],"inflammatory":[24],"disease.":[25],"Although":[26],"thymic":[27,41,55,111,131,141,157,175],"hyperplasia":[28,42,56,142,158,176],"has":[29],"been":[30,186],"described":[31,137],"following":[32,143],"chemotherapy,":[33],"there":[34],"no":[36],"known":[37],"association":[38],"true":[40,54,110,130,140,156],"immune":[44,145],"checkpoint":[45,146],"inhibitor":[46,147],"therapy.":[47],"We":[48,152],"present":[49],"two":[50],"cases":[51,138,161],"suspected":[53],"patients":[58],"stage":[60],"IV":[61],"melanoma":[62],"who":[63],"were":[64,126],"treated":[65],"combination":[68,144],"nivolumab":[70],"ipilimumab,":[72],"which":[73,183],"was":[74],"complicated":[75],"by":[76,86,168,173,188],"immune-related":[77],"toxicity":[78],"requiring":[79,89],"therapy,":[81],"then":[83],"subsequently":[84],"secondary":[87,192],"hypoadrenalism":[88],"replacement":[90],"hydrocortisone.":[91],"In":[92,113],"one":[93],"patient,":[94],"histological":[95],"flurocytometric":[97],"analyses":[98],"an":[100],"incisional":[101],"biopsy":[102],"revealed":[106],"findings":[107,125],"consistent":[108,127],"hyperplasia.":[112,132],"case,":[116],"stable":[118],"fluorodeoxyglucose":[119],"positron":[120],"emission":[121],"tomography/Computed":[122],"tomography":[123],"(FDG-PET/CT)":[124],"These":[133],"are":[134],"first":[136],"therapy":[148,171],"for":[149],"metastatic":[150],"melanoma.":[151],"hypothesize":[153],"that":[154],"these":[160],"results":[162],"from":[163],"initial":[164],"lymphocyte":[165],"depletion":[166],"caused":[167],"intense":[169],"followed":[172],"rebound":[174],"during":[177],"period":[179],"relative":[181],"hypocortisolism,":[182],"may":[184],"have":[185],"aggravated":[187],"onset":[190],"hypoadrenalism.":[193]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-08-13T00:00:00"}